- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 2 x XVD: 6-[2-chloro-6-(trifluoromethoxy)phenyl]-1H-benzimidazol-2-ol(Non-covalent)
- 14 x PLM: PALMITIC ACID(Non-covalent)
PLM.2: 2 residues within 4Å:- Chain A: N.224
- Ligands: PLM.5
No protein-ligand interaction detected (PLIP)PLM.5: 3 residues within 4Å:- Chain B: I.595, L.599
- Ligands: PLM.2
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:I.595, B:L.599
- Salt bridges: B:R.567
PLM.6: 6 residues within 4Å:- Chain B: L.811, S.812, Y.819, I.822, L.825
- Chain C: A.553
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:L.811, B:Y.819, B:I.822, B:I.822, B:L.825
PLM.8: 5 residues within 4Å:- Chain A: Y.206
- Chain B: Y.545, M.549
- Ligands: XVD.1, PLM.9
No protein-ligand interaction detected (PLIP)PLM.9: 4 residues within 4Å:- Chain B: M.549, Y.555
- Ligands: POV.7, PLM.8
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:Y.555
PLM.12: 8 residues within 4Å:- Chain C: Y.544, W.547, I.550, Y.554, L.602, F.605
- Ligands: OLC.11, PLM.13
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:Y.544, C:W.547, C:W.547, C:I.550, C:Y.554, C:L.602, C:F.605
PLM.13: 3 residues within 4Å:- Chain C: Y.554
- Ligands: OLC.11, PLM.12
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:Y.554
PLM.17: 8 residues within 4Å:- Chain D: Y.544, W.547, I.550, Y.554, L.602, F.605
- Ligands: OLC.16, PLM.18
7 PLIP interactions:7 interactions with chain D- Hydrophobic interactions: D:Y.544, D:W.547, D:W.547, D:I.550, D:Y.554, D:L.602, D:F.605
PLM.18: 3 residues within 4Å:- Chain D: Y.554
- Ligands: OLC.16, PLM.17
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:Y.554
PLM.22: 3 residues within 4Å:- Chain E: I.595, L.599
- Ligands: PLM.27
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:I.595, E:L.599
- Salt bridges: E:R.567
PLM.23: 6 residues within 4Å:- Chain D: A.553
- Chain E: L.811, S.812, Y.819, I.822, L.825
5 PLIP interactions:5 interactions with chain E- Hydrophobic interactions: E:L.811, E:Y.819, E:I.822, E:I.822, E:L.825
PLM.25: 5 residues within 4Å:- Chain E: Y.545, M.549
- Chain F: Y.206
- Ligands: PLM.26, XVD.28
No protein-ligand interaction detected (PLIP)PLM.26: 4 residues within 4Å:- Chain E: M.549, Y.555
- Ligands: POV.24, PLM.25
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:Y.555
PLM.27: 2 residues within 4Å:- Chain F: N.224
- Ligands: PLM.22
No protein-ligand interaction detected (PLIP)- 4 x ZK1: {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid(Non-covalent)
ZK1.3: 14 residues within 4Å:- Chain B: E.424, Y.427, Y.472, P.500, L.501, T.502, R.507, G.675, S.676, T.708, L.726, E.727, M.730, Y.754
10 PLIP interactions:10 interactions with chain B- Hydrogen bonds: B:P.500, B:T.502, B:R.507, B:S.676, B:S.676, B:S.676, B:E.727
- pi-Stacking: B:Y.472, B:Y.472
- Halogen bonds: B:Y.754
ZK1.10: 14 residues within 4Å:- Chain C: E.423, Y.426, Y.471, P.499, L.500, T.501, R.506, L.671, G.674, S.675, E.726, T.728, M.729, Y.753
9 PLIP interactions:9 interactions with chain C- Hydrogen bonds: C:P.499, C:T.501, C:R.506, C:R.506, C:S.675, C:S.675, C:S.675
- pi-Stacking: C:Y.471
- Halogen bonds: C:Y.753
ZK1.15: 14 residues within 4Å:- Chain D: E.423, Y.426, Y.471, P.499, L.500, T.501, R.506, L.671, G.674, S.675, E.726, T.728, M.729, Y.753
9 PLIP interactions:9 interactions with chain D- Hydrogen bonds: D:P.499, D:T.501, D:R.506, D:R.506, D:S.675, D:S.675, D:S.675
- pi-Stacking: D:Y.471
- Halogen bonds: D:Y.753
ZK1.20: 14 residues within 4Å:- Chain E: E.424, Y.427, Y.472, P.500, L.501, T.502, R.507, G.675, S.676, T.708, L.726, E.727, M.730, Y.754
10 PLIP interactions:10 interactions with chain E- Hydrogen bonds: E:P.500, E:T.502, E:R.507, E:S.676, E:S.676, E:S.676, E:E.727
- pi-Stacking: E:Y.472, E:Y.472
- Halogen bonds: E:Y.754
- 6 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.4: 7 residues within 4Å:- Chain B: V.536, F.537, Y.819, I.820, G.823, G.824, L.827
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:Y.819, B:L.827
POV.7: 14 residues within 4Å:- Chain A: Y.199, S.200
- Chain B: F.537, L.540, Y.545, E.546, W.548, Y.555, L.603, F.606, I.820
- Chain C: G.624, F.628
- Ligands: PLM.9
11 PLIP interactions:10 interactions with chain B, 1 interactions with chain C- Hydrophobic interactions: B:F.537, B:Y.545, B:Y.545, B:W.548, B:W.548, B:Y.555, B:L.603, B:F.606, B:I.820, C:F.628
- Salt bridges: B:E.546
POV.14: 9 residues within 4Å:- Chain C: V.535, F.536, Y.818, I.819
- Chain F: A.117, L.120, V.124, V.178
- Ligands: OLC.11
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:F.536
POV.19: 11 residues within 4Å:- Chain A: A.117, L.120, V.124, F.130, V.178
- Chain D: V.535, F.536, Y.818, I.819, G.823
- Ligands: OLC.16
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain A- Hydrophobic interactions: D:F.536, A:F.130
POV.21: 7 residues within 4Å:- Chain E: V.536, F.537, Y.819, I.820, G.823, G.824, L.827
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:Y.819, E:L.827
POV.24: 14 residues within 4Å:- Chain D: G.624, F.628
- Chain E: F.537, L.540, Y.545, E.546, W.548, Y.555, L.603, F.606, I.820
- Chain F: Y.199, S.200
- Ligands: PLM.26
11 PLIP interactions:10 interactions with chain E, 1 interactions with chain D- Hydrophobic interactions: E:F.537, E:Y.545, E:Y.545, E:W.548, E:W.548, E:Y.555, E:L.603, E:F.606, E:I.820, D:F.628
- Salt bridges: E:E.546
- 2 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLC.11: 11 residues within 4Å:- Chain C: F.536, Y.544, F.595, L.598, W.599
- Chain E: I.622, G.625, V.626
- Ligands: PLM.12, PLM.13, POV.14
6 PLIP interactions:5 interactions with chain C, 1 interactions with chain E- Hydrophobic interactions: C:F.595, C:L.598, C:W.599, E:I.622
- Hydrogen bonds: C:Y.544, C:Y.544
OLC.16: 11 residues within 4Å:- Chain B: I.622, G.625, V.626
- Chain D: F.536, Y.544, F.595, L.598, W.599
- Ligands: PLM.17, PLM.18, POV.19
6 PLIP interactions:5 interactions with chain D, 1 interactions with chain B- Hydrophobic interactions: D:F.595, D:L.598, D:W.599, B:I.622
- Hydrogen bonds: D:Y.544, D:Y.544
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, D. et al., Modulatory mechanisms of TARP gamma 8-selective AMPA receptor therapeutics. Nat Commun (2023)
- Release Date
- 2023-04-19
- Peptides
- Voltage-dependent calcium channel gamma-8 subunit: AF
Isoform Flip of Glutamate receptor 1: BE
Isoform Flip of Glutamate receptor 2: CD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
IF
JB
CE
AC
DD
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 2 x XVD: 6-[2-chloro-6-(trifluoromethoxy)phenyl]-1H-benzimidazol-2-ol(Non-covalent)
- 14 x PLM: PALMITIC ACID(Non-covalent)
- 4 x ZK1: {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid(Non-covalent)
- 6 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 2 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, D. et al., Modulatory mechanisms of TARP gamma 8-selective AMPA receptor therapeutics. Nat Commun (2023)
- Release Date
- 2023-04-19
- Peptides
- Voltage-dependent calcium channel gamma-8 subunit: AF
Isoform Flip of Glutamate receptor 1: BE
Isoform Flip of Glutamate receptor 2: CD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
IF
JB
CE
AC
DD
B - Membrane
-
We predict this structure to be a membrane protein.